VYNE Therapeutics
VYNE
VYNE
54 hedge funds and large institutions have $12.5M invested in VYNE Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
53% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 17
Holders
54
Holding in Top 10
1
Calls
$95K
Puts
$26K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$169K | |
| 3 | +$128K | |
| 4 |
Goldman Sachs
New York
|
+$75.1K |
| 5 |
VF
Virtu Financial
New York
|
+$68.4K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$994K | |
| 3 | -$347K | |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$200K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$194K |